NRX Pharmaceuticals, Inc. Repayments of Related Party Debt
NRX Pharmaceuticals, Inc. (NRXP) reported Repayments of Related Party Debt of $35.00 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2021-05-14
- NRX Pharmaceuticals, Inc. repayments of related party debt for the quarter ending 2020-12-31 was $35.00K.
- NRX Pharmaceuticals, Inc. repayments of related party debt for the quarter ending 2020-09-30 was $0.00.
- NRX Pharmaceuticals, Inc. repayments of related party debt for the quarter ending 2019-12-31 was $0.00.
- NRX Pharmaceuticals, Inc. repayments of related party debt for the quarter ending 2019-09-30 was $0.00.
- NRX Pharmaceuticals, Inc. repayments of related party debt for fiscal 2020 was $35.00K, a 46.15% decline from fiscal 2019.
- NRX Pharmaceuticals, Inc. repayments of related party debt for fiscal 2019 was $65.00K.
- NRX Pharmaceuticals, Inc. repayments of related party debt for fiscal 2018 was $0.00.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $35.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-14 | $35.00K derived: sum of 2 quarters · filed 2021-05-14 | $35.00K 10-K/A · filed 2021-05-14 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-14 | |||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-05-14 | $65.00K 10-K/A · filed 2021-05-14 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $65.00K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $65.00K 10-Q · filed 2020-08-14 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-30 | |||
| 2017-12-31 | $147.63K 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |